Before the annual congress of the European Society for Medical Oncology began in Barcelona, clinicians held a press ...

Medical device companies are dealing with the impact of increasing regulations in a number of ways, including the ...

Delcath Systems, Inc. , an interventional oncology company focused on liver-directed cancer therapies, today announced the presentation of new subgroup analysis data from the FOCUS Phase 3 trial of ...

An artificial intelligence model was shown to predict tumor mutation burden in lung cancer and other diseases.

In a significant stride toward fostering diversity and inclusivity in dermatology, Medscape Education and the Comprehensive ...

With the new school year kicking off to a great start, The Academy of Interpretation (AOI) is thrilled to announce the continued success of its partnership with Harrisonburg City Public Schools (HCPS) ...

Telehealth respiratory group Respiri says a sales deal with a US group will help the firm achieve cash-flow breakeven status ...

We're celebrating Healthcare Simulation Week 2024 by highlighting the transformative power of our multi-award-winning medical ...

With the training taking place in a virtual environment ... The European Society for Medical Oncology (ESMO) 2024 meeting was a well-attended affair at the sprawling Fira Gran Via centre in ...

Researchers explored HER2 testing discordance, biomarkers of response, patient-reported outcomes, and the risk of lung-related disease.

Key oncology conferences like ASCO, ASH, and ESMO drive investment-informing clinical research, with recent ESMO 2024 data highlighting significant advancements in immunotherapy. Merck's ...

Jazz’s Global Head of R&D Robert Iannone, M.D., told Fierce Biotech ahead of ESMO that today’s updated results “reaffirm zanidatamab’s potential as a foundational treatment for patients ...